GX-E2

DRUG2 trials

Sponsors

Genexine, Inc.

Conditions

AnemiaChronic Kidney DiseaseHealthy

Phase 1

Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy Subjects

CompletedNCT02291991

Genexine, Inc.Healthy

Start: 2014-11-30End: 2015-01-31Updated: 2015-01-29

Phase 2

Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)

CompletedNCT02044653

Genexine, Inc.Anemia, Chronic Kidney Disease

Start: 2014-04-15End: 2017-04-20Updated: 2017-10-16